News Releases

---

Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

 June 14, 2021

---

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

 June 14, 2021

---

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

 May 12, 2021

---

Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy

 March 24, 2021

---

Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference

 February 22, 2021

---

Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference

 September 10, 2020

---

Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board

 July 27, 2020

---

Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV

 June 8, 2020

---

Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV Cures

 May 13, 2020

---

Enochian Biosciences Announces Scientific Presentations at the American Society of Cell and Gene Therapy (ASCGT) Annual Meeting

 April 9, 2020

---

Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV

 February 24, 2020

---

Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or Cure

 February 3, 2020